Below you will find Lilly’s views on certain issues that we are often asked about by customers, policymakers, employees and other stakeholders.
Please visit our Public Policy page for positions related to the U.S. healthcare system, innovation, drug pricing and more.
Strong policies and principles support our goal to ensure that research conducted by our employees or by third parties aligns with our values and complies with relevant local, national and transnational laws and regulations.
To support better health outcomes, Lilly is committed to working with experts to develop tools and solutions to continually improve research and communications so that patients and providers understand and have the health information they need to act.
Lilly’s Bioethics Program
ESG Report | Business Ethics
We take a data-driven approach to DEI so that our business and employee base better reflect the world around us. We recognize that the wide array of races, ethnicities, abilities, ages, religions, sexual orientations, genders and political views in our communities serve as a catalyst for innovation and creativity that contribute to the health and prosperity of society.
Lilly’s values of integrity, excellence and respect for people foster an environment where employees are encouraged to speak up, share ideas and be fully engaged, while bringing their authentic selves to work every day. We strive to create a culture where each person feels welcomed, respected, valued and heard. Our strategic DEI priorities are designed to empower our organization with inclusion capabilities, embed equity in our processes and elevate our business outcomes. We believe that with an inclusive culture, Lilly can innovate, accelerate and deliver life-changing medicines that make a difference.
Lilly is proud to be an Equal Employment Opportunity and Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.
Empowering a Diverse Workforce
Racial Justice Initiative
Diversity and Inclusion Progress Report
ESG Report | Diversity and Inclusion
ESG Report | Our Environmental Approach
Working with a broad array of health care stakeholders, we seek ways to broadly deliver medicines to patients at reasonable out-of-pocket costs with pricing information they can understand.
Lilly recognizes that research outcomes inform the treatment decisions that physicians and other health care providers make for individual patients and contribute to public health initiatives that improve health equity and create better health outcomes. To ensure communities of color have fair access to and representation in our research, we strive for diversity among clinical trial participants, trial sites and investigators. Our robust clinical trial strategy prioritizes partnerships and collaboration to reach diverse populations.
Increase Access to Medicines
Diversity in Clinical Research
Lilly Diabetes Solution Center
Reimagining Equitable Cancer Care Is Achievable
ESG Report | Human Rights
We set high standards for our products, operations and performance and we are always seeking opportunities to enhance these areas.
Lilly’s robust code of conduct, policies and procedures governing behavior in the workplace – along with required employee annual training in ethical business practices – reinforce a culture of integrity and ethical behavior. We encourage employees to seek guidance when the ethical or legal thing to do is not clear and to report any concerns in a timely manner.
Employees can report concerns to leadership, as well as human resources, ethics and compliance, or legal. The Lilly Ethics and Compliance Hotline is available 24 hours a day to employees and the public globally, subject to local law, via phone at 1-800-815-2481, online or via email at email@example.com. The hotline website also lists up-to-date local phone numbers for most countries, where available. Translation services are available, and reports may be made anonymously.
Operate Ethically and Responsibly
ESG Report | Business Ethics
Beginning with the discovery of a potential new medicine, and for as long as it is available to patients, our goal is to ensure that the benefits and risks of a medication are continuously monitored and well-understood by regulators, health care providers and patients.
Our Global Patient Safety organization is dedicated to the collection, monitoring, evaluation and reporting of safety information and we communicate new safety findings to patients, health care professionals, and regulators.
Lilly is also committed to manufacturing high-quality medicines. We carefully monitor our manufacturing facilities in order to meet Good Manufacturing Practices (GMP) and quality manufacturing standards set by the U.S. Food and Drug Administration (FDA) and other regulatory agencies around the world.
Safety Matters at Lilly
Our Commitment to Patient Safety